Five recipients of ActiGraph's Digital Endpoint Accelerator Research “DEAR” Grant to validate fit-for-purpose uses of DHTs in clinical populations have been announced.
The Digital Medicine Society (DiMe) releases new set of resources to advance the use of digitally measured nocturnal scratch as a meaningful endpoint for atopic dermatitis (AD).